Core Viewpoint - The research team from Shenzhen Medical Academy and Peking University published a significant paper in the inaugural issue of the journal Vita, highlighting advancements in understanding the fast inactivation of human Nav1.7 channels [1][3]. Group 1: Research Publication - The study was first published on the "Langtaosha Preprint Platform" on November 18, 2025, becoming the first paper on the platform, with nearly 8,000 views and over 2,000 downloads [3]. - The paper underwent rigorous peer review before being officially published in the high-level international journal Vita, which is part of the Life Sciences Open Alliance [3][5]. Group 2: Journal and Platform Development - Vita journal emphasizes a "zero OA fee" policy and aims to return to academic roots, promoting immediate open sharing of research results through the Langtaosha platform [5][6]. - The collaboration between the journal and the preprint platform provides a rapid sharing channel for scientists in the life sciences and biomedical fields, enhancing academic communication [7]. - The establishment of Vita responds to the need for top-tier journals in China's life sciences sector, which has seen significant advancements in research capabilities over the past decade [7][8]. Group 3: Future Plans and Structure - Vita plans to create a professional editorial team to ensure high academic standards and will not charge authors any OA or publication fees [8]. - The journal's first batch of original papers is in the final review stage and is expected to launch in the first quarter of this year, with the print edition scheduled for June 2026 [8].

Core Viewpoint - The research article titled "Open-state structure of veratridine-activated human Nav1.7 reveals the molecular choreography of fast inactivation" was published by a collaborative team from Shenzhen Medical Academy and Peking University in the inaugural issue of the journal Vita, highlighting advancements in the field of life sciences and biomedical research [1][3]. Group 1: Research Publication - The study was first published on the "Langtaosha Preprint Platform" on November 18, 2025, becoming the first paper on the platform, with nearly 8,000 views and over 2,000 downloads [3]. - The article underwent rigorous peer review before being officially published in the high-level international journal Vita, which is part of the Life Sciences Open Alliance [3][5]. Group 2: Journal and Platform Development - The Vita journal promotes a "zero OA fee" policy and emphasizes the return to academic fundamentals, facilitating immediate open sharing of research results through the Langtaosha platform [5][6]. - The collaboration between the journal and the preprint platform aims to provide a rapid sharing channel for scientific results and establish a core platform for academic exchange in life sciences and biomedicine [7]. - The establishment of Vita responds to the need for top-tier journals in China's life sciences sector, which has seen significant advancements in research capabilities over the past decade [7][8]. Group 3: Editorial and Publication Strategy - Vita aims to build a professional editorial team to ensure the innovation and authority of published results, while maintaining an open-access model without charging authors any fees [8]. - The journal's first batch of original papers is in the final review stage and is expected to launch in the first quarter of this year, with the print edition scheduled for June 2026 [8].

Core Insights - The article discusses the establishment of a new international open-access journal named Vita, led by Westlake University, focusing on significant advancements in life sciences and biomedical research [2] - It highlights the unique characteristics of childhood cancers, emphasizing their developmental origins and the potential for a unified mechanism of onset [7][11] Group 1: Journal Overview - Vita is co-edited by Professor Li Dangsheng and Professor Shi Yigong, aiming to publish impactful research in various fields of life sciences [2] - The journal has already published two articles, including an "Expert Views" piece and a "Cutting Edge" commentary [3] Group 2: Childhood Cancer Mechanisms - The article presents a perspective on the common origin mechanisms of childhood tumors from a developmental biology viewpoint, contrasting them with adult cancers [7][9] - It identifies that childhood cancers primarily affect the hematopoietic system (e.g., leukemia) and the nervous system (e.g., brain tumors), which are most susceptible to malignancy during early development [10][11] Group 3: Developmental Vulnerabilities - The article explains that during embryonic development, tissue-forming cells (TFCs) act as "builders" of organs, and disruptions in their protective mechanisms can lead to mutations and cancer [13][14] - It discusses the similarities in the developmental processes of the hematopoietic and nervous systems, which may explain the prevalence of childhood cancers in these areas [15][16] Group 4: Future Directions - The authors suggest that understanding the developmental vulnerabilities can provide new strategies for preventing childhood cancers, including the potential use of protective molecules delivered through the placenta [21][24] - Future research directions include identifying similar genomic protection mechanisms in other organs and developing early intervention strategies for high-risk pregnancies [23][24]

Core Viewpoint - The launch of the international journal "Vita" in the field of life sciences and biomedicine is a response to the growing demand for high-quality academic publications in China, aiming to establish a world-class scientific journal led by China and recognized internationally [1][3]. Group 1: Journal Development - "Vita" will officially debut in spring 2026, with the first batch of original papers undergoing final review and set to be published in the first quarter of 2026 [3]. - The journal has received its international standard serial number and has established an expert advisory committee with nearly 100 top scientists from both domestic and international backgrounds [3]. - The print version of "Vita" is scheduled for release in June 2026 [3]. Group 2: Academic Standards and Accessibility - The journal aims to create a specialized editorial team to ensure high academic standards, focusing on the innovation and authority of published results [3]. - "Vita" will not charge authors any open access fees or publication fees, promoting an open and shared academic environment [3]. - The journal will explore a new model of "evaluation by articles" to return to the essence of academic publishing [3].